| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
4-Alkyl- and 4-phenylcoumarins from Mesua ferrea as promising multidrug resistant antibacterials.
|
Phytochemistry
|
2004
|
1.74
|
|
2
|
Antiangiogenic and antitumor activity of IDN 5390, a new taxane derivative.
|
Clin Cancer Res
|
2002
|
1.09
|
|
3
|
Silybin and its bioavailable phospholipid complex (IdB 1016) potentiate in vitro and in vivo the activity of cisplatin.
|
Life Sci
|
2002
|
0.94
|
|
4
|
Hypoglycemic effect of lupin seed γ-conglutin in experimental animals and healthy human subjects.
|
Fitoterapia
|
2011
|
0.89
|
|
5
|
Characterization of the pharmacologic profile of a standardized soy extract in the ovariectomized rat model of menopause: effects on bone, uterus, and lipid profile.
|
Menopause
|
2005
|
0.89
|
|
6
|
The hyperforin derivative IDN5706 occludes spatial memory impairments and neuropathological changes in a double transgenic Alzheimer's mouse model.
|
Curr Alzheimer Res
|
2010
|
0.88
|
|
7
|
Potential efficacy of preparations derived from Phaseolus vulgaris in the control of appetite, energy intake, and carbohydrate metabolism.
|
Diabetes Metab Syndr Obes
|
2009
|
0.88
|
|
8
|
Effect of the silybin-phosphatidylcholine complex (IdB 1016) on the development of mammary tumors in HER-2/neu transgenic mice.
|
Cancer Res
|
2007
|
0.87
|
|
9
|
Topical anti-inflammatory activity of extracts and compounds from Hypericum perforatum L.
|
J Pharm Pharmacol
|
2007
|
0.86
|
|
10
|
Reducing effect of a Phaseolus vulgaris dry extract on food intake, body weight, and glycemia in rats.
|
J Agric Food Chem
|
2009
|
0.83
|
|
11
|
Inhibition of SIRT2 potentiates the anti-motility activity of taxanes: implications for antineoplastic combination therapies.
|
Neoplasia
|
2012
|
0.82
|
|
12
|
Estradiol and phytoestrogens differently influence the rodent postmenopausal mammary gland.
|
Menopause
|
2006
|
0.82
|
|
13
|
Phaseolus vulgaris extract affects glycometabolic and appetite control in healthy human subjects.
|
Br J Nutr
|
2012
|
0.81
|
|
14
|
Second generation taxanes: from the natural framework to the challenge of drug resistance.
|
Curr Med Chem Anticancer Agents
|
2003
|
0.81
|
|
15
|
Synthesis and biological evaluation of 2'-methyl taxoids derived from baccatin III and 14beta-OH-baccatin III 1,14-carbonate.
|
J Med Chem
|
2003
|
0.81
|
|
16
|
Identification of miltirone as active ingredient of Salvia miltiorrhiza responsible for the reducing effect of root extracts on alcohol intake in rats.
|
Alcohol Clin Exp Res
|
2006
|
0.80
|
|
17
|
Binding studies of taxanes to human serum albumin by bioaffinity chromatography and circular dichroism.
|
J Pharm Biomed Anal
|
2006
|
0.79
|
|
18
|
Beneficial effects of artichoke leaf extract supplementation on increasing HDL-cholesterol in subjects with primary mild hypercholesterolaemia: a double-blind, randomized, placebo-controlled trial.
|
Int J Food Sci Nutr
|
2012
|
0.78
|
|
19
|
Metabolic management in overweight subjects with naive impaired fasting glycaemia by means of a highly standardized extract from Cynara scolymus: a double-blind, placebo-controlled, randomized clinical trial.
|
Phytother Res
|
2013
|
0.78
|
|
20
|
Liquid chromatography/atmospheric pressure chemical ionization ion trap mass spectrometry of bilobalide in plasma and brain of rats after oral administration of its phospholipidic complex.
|
J Pharm Biomed Anal
|
2009
|
0.78
|
|
21
|
Management of gastrointestinal mucositis due to cancer therapies in pediatric patients: results of a case series with SAMITAL(®).
|
Future Oncol
|
2012
|
0.78
|
|
22
|
Dietary soy modulation of biochemical parameters in DMBA-induced mammary tumors.
|
Cancer Lett
|
2002
|
0.78
|
|
23
|
Protective effect of Panax ginseng in cisplatin-induced cachexia in rats.
|
Future Oncol
|
2014
|
0.77
|
|
24
|
Reducing effect of an extract of Phaseolus vulgaris on food intake in mice--focus on highly palatable foods.
|
Fitoterapia
|
2012
|
0.77
|
|
25
|
Reducing effect of a Phaseolus vulgaris dry extract on operant self-administration of a chocolate-flavoured beverage in rats.
|
Br J Nutr
|
2010
|
0.77
|
|
26
|
Multiple cycles of repeated treatments with a Phaseolus vulgaris dry extract reduce food intake and body weight in obese rats.
|
Br J Nutr
|
2011
|
0.77
|
|
27
|
Reducing effect of a combination of Phaseolus vulgaris and Cynara scolymus extracts on food intake and glycemia in rats.
|
Phytother Res
|
2012
|
0.76
|
|
28
|
IDN 5390: a new concept in taxane development.
|
Anticancer Drugs
|
2003
|
0.76
|
|
29
|
Potential antidepressant properties of IDN 5491 (hyperforin-trimethoxybenzoate), a semisynthetic ester of hyperforin.
|
Eur Neuropsychopharmacol
|
2005
|
0.76
|
|
30
|
LC-MS characterization of terpene lactones in plasma of experimental animals treated with Ginkgo biloba extracts Correlation with pharmacological activity.
|
J Pharm Biomed Anal
|
2005
|
0.76
|
|
31
|
SAMITAL®: a new botanical drug for the treatment of mucositis induced by oncological therapies.
|
Future Oncol
|
2013
|
0.76
|
|
32
|
Reducing effect of a combination of Phaseolus vulgaris and Cynara scolymus extracts on operant self-administration of a chocolate-flavoured beverage in rats.
|
Phytother Res
|
2012
|
0.76
|
|
33
|
In vitro effects of the dicyclohexylammonium salt of hyperforin on interleukin-6 release in different experimental models.
|
Planta Med
|
2004
|
0.75
|
|
34
|
Effects of thiocolchicine on axonal cytoskeleton of the rat peroneus nerve.
|
Exp Toxicol Pathol
|
2002
|
0.75
|
|
35
|
Evidence of glycemia-lowering effect by a Cynara scolymus L. extract in normal and obese rats.
|
Phytother Res
|
2010
|
0.75
|
|
36
|
Synthesis and HSA binding characterisation of the water soluble 7-succinylpaclitaxel.
|
Eur J Med Chem
|
2003
|
0.75
|
|
37
|
3-demethoxy-3-glycosylaminothiocolchicines: Synthesis of a new class of putative muscle relaxant compounds.
|
J Med Chem
|
2006
|
0.75
|
|
38
|
Novel 3-O-glycosyl-3-demethylthiocolchicines as ligands for glycine and gamma-aminobutyric acid receptors.
|
J Med Chem
|
2007
|
0.75
|
|
39
|
Effect of SAMITAL® in the treatment of chemotherapy-induced mucositis in adult oncohematological patients.
|
Future Oncol
|
2013
|
0.75
|